BlueOcean Swiss STO (BOV)

First Tokenized Medtech VC Fund

"BlueOcean Ventures is a Swiss venture capital firm specialized in investing in ventures from the medical field. For the first time, the BlueOcean STO gives investors the possibility of buying a tradable token (BOV Token) in the highly illiquid asset class of Swiss and European Medtech and life science venture capital investments. 5 Existing portfolio companies, This STO will allow investing in more startups in order to reach a portfolio size of 8 to 12."


(https://blueocean.swiss)

Start Date

15 Oct, 2018

End Date

21 Dec, 2018

BlueOcean Swiss Use of Token

BOV tokens are standard ERC20 tokens. Investors who will purchase BOV tokens will become indirect shareholders into BlueOcean Ventures II. A total of 50,000,000 BOV will be created.

  • Organization

    SwissVCToken Pte Ltd

  • Platform

    Ethereum

  • Coin type

    Security Token

  • Category

    Healthcare

  • Soft cap

    3,200,000

  • Max cap

    36,000,000

  • Max supply

    50,000,000 BOV

  • Price

    1

BlueOcean Swiss Token Sale Stages

  • Stage
  • Start date
  • End date
  • Amount of Tokens
  • Price
  • Discount
    • Private Sale
    • 15 October, 2019
    • 15 January, 2019
    • 1
    • 60
    • Claim
    • Private Sale
    • 15 January, 2019
    • 15 February, 2019
    • 1
    • 30
    • Claim
    • Public Sale
    • 15 February, 2019
    • 31 March, 2019
    • 1
    • Claim

BlueOcean Swiss Distribution

BlueOcean Swiss Use of Proceeds

BlueOcean Swiss Team Members

  • Emmanuel de Watteville
    Emmanuel de Watteville General Partner and Co-Founder
  • Thomas Zehnder
    Thomas Zehnder General Partner
  • Jean-Etienne Durand
    Jean-Etienne Durand Head of Operations

BlueOcean Swiss Advisors

  • Lug Giroud
    Lug Giroud Advisor
  • Christophe Saam
    Christophe Saam Advisor
  • Olivier Crochat
    Olivier Crochat STO Technology Advisor

BlueOcean Swiss Past Events

  • 31 December, 2019

    Launch of BlueOcean Ventures I

  • 31 December, 2019

    Launch of the second fund, BlueOcean Ventures II

  • 31 December, 2019

    BlueOcean Ventures II invests in Ava AG, Rheon Medical SA, and Abionic SA

  • 31 December, 2019

    BlueOcean Ventures II achieves an impressive 48% growth of its portfolio value until end 2017 (audited numbers)

  • 31 May, 2019

    Set up of Special STO Investment Vehicle in Singapore

  • 31 July, 2019

    BlueOcean Ventures II invest in Volumina Medical SA and Luciole Medical AG, Start of the presale of the STO

  • 31 December, 2019

    End of the STO. 100% of the STO net proceeds are invested into BlueOcean Ventures II

  • 31 January, 2019

    BOV token trades on various exchanges and BlueOcean Ventures II has a portfolio of 6 startups

  • 31 December, 2019

    BlueOcean Ventures II has a portfolio of 8 to 12 companies. Initial expected proceed to token holders from first sale of a portfolio company

  • 31 December, 2019

    BlueOcean Ventures II is closed, all remaining assets are distributed to the investors